Different response to rituximab in tumor necrosis factor blocker-naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: A twenty-four-week clinical trial-Reference-Cited by-同舟云学术

Different response to rituximab in tumor necrosis factor blocker-naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: A twenty-four-week clinical trial

Published:2010-04-29 Issue:5 Volume:62 Page:1290-1297
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

Song I.-H.,Heldmann F.,Rudwaleit M.,Listing J.,Appel H.,Braun J.,Sieper J.

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference53 articles.

1. Ankylosing spondylitis;Braun;Lancet,2007

2. ASAS/EULAR recommendations for the management of ankylosing spondylitis;Zochling;Ann Rheum Dis,2006

3. Six months open label trial of leflunomide in active ankylosing spondylitis;Haibel;Ann Rheum Dis,2005

4. Open label trial of anakinra in active ankylosing spondylitis over 24 weeks;Haibel;Ann Rheum Dis,2005

5. No efficacy of subcutaneous methotrexate in active ankylosing spondylitis: a 16-week open-label trial;Haibel;Ann Rheum Dis,2007

Cited by 167 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiogenesis-related immune response may be the prelude to the syndesmophyte formation in Ankylosing spondylitis;International Immunopharmacology;2024-05

2. Fibroblast Insights into the Pathogenesis of Ankylosing Spondylitis;Journal of Inflammation Research;2023-12

3. Bruton’s Tyrosine Kinase in Ankylosing Spondylitis;Spine;2023-09-14

4. Uncovering the Underworld of Axial Spondyloarthritis;International Journal of Molecular Sciences;2023-03-30

5. Exploration of the shared pathways and common biomarker PAN3 in ankylosing spondylitis and ulcerative colitis using integrated bioinformatics analysis;Frontiers in Immunology;2023-01-18